Battery Global Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$89.6K Hold
1,436
– – 0.04% 64
2026
Q2
$82.7K Hold
1,436
– – 0.04% 65
2026
Q1
$87.1K Hold
1,436
– – 0.05% 62
2025
Q4
$77.5K Hold
1,436
– – 0.04% 66
2025
Q3
$64.8K Hold
1,436
– – 0.03% 67
2025
Q2
$66.5K Hold
1,436
– – 0.03% 64
2025
Q1
$87.6K Hold
1,436
– – 0.05% 52
2024
Q4
$81.2K Hold
1,436
– – 0.04% 53
2024
Q3
$74.3K Buy
+1,436
New +$67.4K 0.04% 59

Other funds holding BMY

Battery Global Advisors's BMY Position: Q3 2026 in Review

Battery Global Advisors held its Bristol-Myers Squibb (BMY) position steady in Q3 2026 at 1,436 shares worth $89.6K. The position accounts for 0.04% of the portfolio, ranked #64.

Battery Global Advisors first reported a position in BMY in Q3 2024 and has held it in 9 quarters since. 1,763 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Battery Global Advisors held 1,436 shares of Bristol-Myers Squibb worth $89.6K as of Q3 2026.
  • Battery Global Advisors left its Bristol-Myers Squibb share count unchanged in Q3 2026.
  • Bristol-Myers Squibb made up 0.04% of Battery Global Advisors's portfolio in Q3 2026, its #64 holding.
  • Battery Global Advisors first reported a position in Bristol-Myers Squibb in Q3 2024 and has held it in 9 quarters since.
  • 1,763 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Battery Global Advisors's 13F filing for Q3 2026, filed 10 Nov 2026.